Radio Advisory

There has been a lot of change in the oncology space in the last few years. These changes have brought new pressures, like workforce strain, increased competition, rising spend, and more. While many leaders are worried about the "right now," it is crucial to consider how you can best position yourself for the future of cancer care. That's why, in this episode, host Rachel (Rae) Woods invites Advisory Board specialty care experts Lindsey Paul and Julia Elder to discuss why preparing for the future means making changes today. Throughout the conversation, they discuss how current pressures are changing the field of oncology and four ways cancer care will change by 2030. Links: 4 predictions for cancer care in 2030 3 strategies to leverage oncology pharmacists and improve cancer care 5 strategies to deploy (and empower) APPs in cancer care Ep. 203: Value series: Is the future of VBC in specialty care? Zing Health & Strive Health say yes. Ep. 202: Value series: Why CenterWell (and Humana) is going all in on senior care Register for the Clinical Innovation Summit A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

According to economist Jim Rebitzer and healthcare consultant Bob Rebitzer, the healthcare industry has failed in achieving what many other sectors have accomplished – improving products, while simultaneously reducing costs over time. In this episode, recorded live at The Players 2024 Championship, host Rachel (Rae) Woods invited Jim and Bob to discuss the central premise of their book, Why Not Better and Cheaper? They discussed the root causes of this challenge – including incentives, prevailing professional and social norms, and competition – that the industry must confront to deliver better and cheaper healthcare. Links: Learn more about the Rebitzer brothers and their new book, Why Not Better and Cheaper? Our Financial Impact playlist This spring Radio Advisory is celebrating four years of production. Thank you for listening! Truly personalized care is possible. Here's how to make it a reality. Learn about Advisory Board On-Demand Courses Learn about Advisory Board Fellowship A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

Radio Advisory has commemorated Nurses Week every year since we started production in April 2020. A lot has changed since the early days of the pandemic, but the reality is that we’re still grappling with a workforce crisis defined by rising burnout, turnover, and shortages. Celebrating nurses just one week out of the year will not suffice in addressing these complex issues. In this episode, host Rachel (Rae) Woods sits down with Advisory Board nursing experts Monica Westhead, Allyson Paiewonsky, and Ali Knight to discuss why the industry needs to pivot towards more sustainable strategies for their care teams, what leaders should be thinking about when training and supporting nurses, and why "top-of-license care" is an incomplete solution. Links: [Webinar] How to cultivate resilient and adaptive nurse leaders 4 ways to retain early career nurses 3 underlying causes of nurse recruitment and retention challenges A detailed look at the top 2 models for virtual nursing care 3 ways AI can help nurses AI nurses? Inside Nvidia, Hippocratic AI's new partnership Our Clinical Workforce playlist Ep. 205: Live from ViVE 2024: Four leaders on how technology is redefining clinical work Ep. 162: Addressing the workforce crisis: Insights from University Hospitals' leaders Ep. 135: Henry Ford Health on nursing shortages and the real supply chain issue 6 advantages to matching patients with compatible clinicians (sponsored by Optum Match) Learn about Advisory Board Fellowship [Webinar, May 14] Bespoke care, part 1: What it is and how it’s transforming care delivery A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

As healthcare leaders continue to contend with workforce shortages, technological shifts, and fragile financials it can be hard to predict what the future looks like for their organizations and the transformation that needs to happen to improve healthcare for all. In this episode, host Rachel (Rae) Woods invites the 24th Secretary of the U.S. Department of Health and Human Services Alex Azar to discuss what "transformation" actually means, what conditions need to be in place to mitigate financial loss, and what leaders can do to advance towards industry-wide transformation. Links: Our Value-based Care playlist Around the nation: CMS hints at more prior authorization rules Our Strategy playlist Truly personalized care is possible. Here's how to make it a reality. [Webinar, May 14] Bespoke care, part 1: What it is and how it’s transforming care delivery A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

You might be burned out from talking about burnout. But the truth is, healthcare workers are still suffering from high administrative burden, reduced autonomy, and a cycle of turnover and retirements that we cannot escape. In response, industry leaders are looking to the latest and greatest technologies to unburden their workforce and improve the mental wellbeing of their staff. But will the promise of a tech-enabled clinical workforce live up to the hype? In this special episode, recorded live from ViVE 2024, host Rachel (Rae) Woods invites Dr. Nele Jessel, Chief Medical Officer at athenahealth, Dr. Jesse Ehrenfeld, President of the American Medical Association, Dr. Syl Trepanier, SVP and System Chief Nursing Officer at Providence, and Dr. Tina Shah, Chief Clinical Officer at Abridge, to discuss the state of the workforce crisis, how new technologies are redefining work, and why emerging technologies like AI might not be a silver bullet. Links: Cloud-Based Healthcare Products & Services | athenahealth American Medical Association (ama-assn.org) World-class health care with human connection | Providence Abridge | Generative AI for Clinical Conversations How technology can help solve the workforce crisis Truly personalized care is possible. Here's how to make it a reality. [Webinar, May 14] Bespoke care, part 1: What it is and how it’s transforming care delivery A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

High-cost drugs, generative AI, diagnostic testing – the pace and sophistication of healthcare innovation has been keeping our experts busy over the past several years. At some point, they realized there was something deeper going on – a sea change in what healthcare innovation is seeking to achieve, and the world it's pushing us toward. This week, host Abby Burns invites Advisory Board innovation experts Solomon Banjo and Nick Hula to talk about a new era of innovation, where progress in diagnostics, treatments, data analysis, and ongoing management have the potential to revolutionize patient care through unprecedented customization. They define what "bespoke care" is, explain how it differs from other delivery models, and highlight the opportunities (and challenges) it presents. Want to learn more about bespoke care and what it means for the industry? Register for our upcoming webinar series in May. Links: [Webinar, May 14] Bespoke care, part 1: What it is and how it’s transforming care delivery 4 imperatives for the future of healthcare innovation Truly personalized care is possible. Here's how to make it a reality. Researchers react: Quick takes on the Clinical Innovation Summit New advances in treatment and diagnostics have the potential to deliver on one of healthcare's greatest unrealized promises: truly personalized, patient-focused care. But how can a system designed to deliver fast, standardized treatment realign itself to offer "bespoke care" to patients at scale? Visit advisory.com/bespoke to learn 4 key challenges standing in the way – and how to overcome them. Radio Advisory is celebrating its four-year anniversary this month! Tell us about your favorite episode, what you like about the podcast, and how we can continue to do better by emailing [email protected] or leave us a voicemail through radioadvisory.advisory.com. Thanks for listening! A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

Last week, in part two of our series on value-based care, we talked about how CenterWell, Humana’s provider arm, turned to senior-focused primary care to grow their value-based strategy. But as the Medicare Advantage market gets larger, older, and sicker, it is becoming clear that a focus on primary care isn’t enough. The fact is, VBC in specialty care is the future. In part three of our value series, host Rachel (Rae) Woods invites TJ Ackerman, Senior Vice President of Provider and Network Performance at Zing Health, to discuss what good specialty care in Medicare Advantage looks like. We also talk with one of Zing’s provider partners, Will Stokes, Chief Strategy Officer at Strive Health, a leader in value-based kidney care. Together, TJ and Will discuss the importance of payer-provider partners in value-based specialty care. Links: Zing Health offers Medicare Advantage Plans in Illinois, Indiana, and Michigan. (myzinghealth.com) Transforming Kidney Care - Strive Health Register for the “Raising the Value Bar Summit” Ep. 202: Value series: Why CenterWell (and Humana) is going all in on senior care Ep. 201: Value series: What does health system VBC adoption actually look like? Use the Market Scenario Planner Learn about Advisory Board On-Demand Courses Register for the Raising the Value Bar Summit 3 strategies for facing the 'tripledemic' of respiratory viruses A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

Last week, in part one of our series on value-based care, we talked all about health systems taking on risk, and why that looks a bit different for everyone. This week, we're exploring an organization that embodies that principle. CenterWell, Humana's provider arm, is pursuing value-based care by going all in on senior focused care. So how are they doing it? In part two of our value series, host Rachel (Rae) Woods invites CenterWell President, Dr. Sanjay Shetty, to discuss the philosophy behind and strategies for pursuing value-based care through senior care management. Throughout the conversation, they discuss why this strategy is right for CenterWell, what it takes to succeed, and how they are navigating today's market challenges. Links: CenterWell | Reimagining Senior Healthcare Register for the "Raising the Value Bar Summit Ep. 201: Value series: What does health system VBC adoption actually look like? 5 insights from VBC leaders 3 strategies for facing the 'tripledemic' of respiratory viruses How CoxHealth grew their Inspire program to meet surging demand Learn about Advisory Board Fellowship A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

In a few weeks, Advisory Board will be convening leaders across the industry in New Orleans, Louisiana to talk about the meaning of "value" in healthcare. In anticipation of the Value Summit, Radio Advisory will be spending the next three weeks talking about one major expression of value in the industry – value-based care. In the first episode of our mini-series, host Abby Burns invites Advisory Board value-based care experts Clare Wirth and Daniel Kuzmanovich to paint the landscape of health system VBC adoption and break down why the road to VBC is neither linear, nor uniform. Links: Register for the "Raising the Value Bar Summit" VBC self-assessment: Find out where your organization stands 5 insights from VBC leaders Introduction to the series: Envisioning paths to nationwide VBC Ep. 178: What the industry is (still) getting wrong about value-based care Learn more about On-Demand Courses How St. Cloud ENT partnered with an ASC to improve sleep apnea outcomes and grow surgical services A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

In the last five years, the health care industry has seen an explosion of corporate ownership over medical groups. It's been relatively smooth sailing for many of these groups so far—but in 2024, they may face the same challenges as incumbents. In this episode, host Rachel (Rae) Woods invites Advisory Board physician experts Sarah Roller and Eliza Dailey to discuss why 2024 will be a make-or-break year for corporate medical groups, and what that means for the rest of the industry. Links: Bold predictions for healthcare in 2024 What you need to know about rising medical group consolidation Physician employment is changing. What does that mean for the industry? Ep. 198: PE firm General Catalyst is buying a hospital — here's our take Use Advisory Board's Clinician Supply Profiler to see how physician supply in your market compares to others. Register for Advisory Board's Clinical Innovation Summit and learn about sponsorship opportunities. Learn more about Advisory Board Fellowship. A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

Producers' note: We know a lot of organizations have been and are being affected by the major cyberattack of Change Healthcare systems and resulting outages. We won't be addressing it in this episode, but if you have questions or are looking for more information please go to https://www.unitedhealthgroup.com/changehealthcarecyberresponse. The relationship between health plans and providers has always included an element of friction, but lately, it seems like the temperature is rising. And you've probably noticed – public contracting disputes increased by 69% between 2022 and 2023. That's why, in this episode, host Abby Burns invites Advisory Board experts Max Hakanson and Eileen Fennell to discuss why the state of affairs seems to be getting worse, how key flashpoints are fanning the flames, and what each stakeholder says they need to see from their partners in order to mend the relationship. Plus, Advisory Board digital health expert Ty Aderhold makes a cameo appearance to help answer the question: Is AI the solution here? Links: 7 things we want to fix in 2024 (and how to get there) A new era of payer-provider relationships The new era of provider enablement AI in healthcare: Insights from 10 C-suite executives 2024 Raising the Value Bar Summit A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

Corporate entities like health plans, retail companies, and PE firms have aggregated large, diverse portfolios of care delivery assets over the past decade – with one notable exception: no one was buying hospitals. But in January, venture capital firm General Catalyst bucked that trend and announced its intent to acquire Summa Health, a 3-hospital health system in northeastern Ohio. What are they thinking? And what could this mean for the industry? In this episode, host Rachel (Rae) Woods and co-host Abby Burns invite Advisory Board's health system expert Vidal Seegobin to unpack the details of the story, interpret General Catalyst's ambition, and share what they'll be watching in the coming months. Links: Radio Advisory's financial impact playlist Survey insights: 6 priorities for health system strategists in 2024 Ep. 193: Is health system growth still possible? Ep. 123: Is private equity health care's bad guy? The Hospital Benchmark Generator Improving detection of ATTR-CM: Insights from experts A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

Artificial intelligence has been rocking industries across the world, and healthcare is no exception. But what impact will it have exactly on physicians? Health systems? Data sovereignty? In this episode, host Rachel (Rae) Woods passes the microphone to Eric Larsen, President Emeritus of Advisory Board and President of TowerBrook Advisors. In this conversation, Eric sits down with Dr. John Halamka, President of the Mayo Clinic Platform, to demystify how the industry should think about generative AI across all of healthcare. Links: Ep. 185: AI adoption: why you can't afford to "wait and see" Ep. 180: Tom Lawry on why AI has a PR problem Lessons from the C-suite AI in healthcare: Insights from 10 C-suite executives Learn more about Advisory Board Sponsorship Learn more about Advisory Board's 2024 Revolutions in Specialty Care Summit A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

Headlines about the future of surgery often focus on robots in the operating room– but innovation in surgical care and operations goes beyond robotics. In reality, the solutions to surgery leaders' problems – like inefficiency and dwindling margins – may be less futuristic than you'd think. In this episode, host Rachel (Rae) Woods invites Advisory Board experts Isis Monteiro, Miles Cottier, and Paul Trigonoplos to discuss what is next for the future of surgery, and what it will actually take for health systems to make surgical care profitable again. They discuss innovations in the OR, opportunities to improve efficiency, and why it might be time to think differently about the future of surgery. Links: Mentioned in the interview (15:00): Open source code that optimizes operating room efficiency Ep. 142: The dire state of hospital finances (Part 1: Hospital of the Future series) Ep. 193: Is health system growth still possible? General surgery service line outlook – 2023 [Webinar on Feb. 27] How health systems are preparing for the future of surgery Use the Market Scenario Planner tool Learn more about Advisory Board's 2024 Revolutions in Specialty Care Summit A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

The data doesn't lie: site-of-care shifts are accelerating. Health systems rely on surgical volumes as a major revenue driver, but as more procedures take place outside of the hospital, systems are not necessarily positioned to capture the shift in volumes – or revenues. So, what should health systems do? To answer that question, host Abby Burns talks with Advisory Board experts Nick Hula and Sebastian Beckmann. They discuss why health systems need to transition from a "defensive" to "offensive" approach to capture shifting volumes and identify service- and market-level factors systems should consider when putting this mindset shift into action. Links: Site-of-care shifts: The next savings opportunity for health plans? Ep. 193: Is health system growth still possible? 5 trends (re)shaping site-of-care shifts What's happening with joint replacement volumes? Learn more about Advisory Board's on-demand courses Learn more about the Advisory Board Fellowship at: advisory.com/fellowship A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

We've all seen headlines about decreasing quality in U.S. healthcare. In an industry battling with workforce shortages, rising health needs, missed prevention, workplace violence, and rising healthcare needs, it's no wonder quality is falling and adverse events are rising. The fact is: in 2024, the patients are not all right. In this episode, host Rachel (Rae) Woods talks with Advisory Board equity expert Darby Sullivan about the state of clinical quality. Following that, we hear from Dr. David Baker, Executive Vice President for Healthcare Quality Evaluation and Improvement at The Joint Commission, to discuss why patient quality is declining and what the industry can do to improve it. In the conversation, they discuss how we define and measure clinical quality, what leaders can do to improve outcomes, and more. Links: The Joint Commission How to tackle the 4 root causes of stagnating clinical quality 4 ways to 'fire-proof' your quality efforts Is clinical quality declining? A look at the data — and what you can do. Learn more about Advisory Board's on-demand courses How UPMC improved interdisciplinary care for metastatic breast cancer and geriatric patients A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

Between high labor costs, inflation, workforce shortages, and a host of other challenges, the past couple of years have been some of the most straining financial times for health systems in recent memory. Though the tides may be starting to turn, it is critical that health systems do not get complacent. How can health systems prepare to grow in the midst of an optimistic yet volatile landscape? Paradoxically, the growth path for health systems is actually to shrink. That’s why, in this episode, host Rachel (Rae) Woods invites Advisory Board health systems expert Vidal Seegobin, and quantitative insights expert Larry Watts to discuss why heath systems might have to first shrink in order to grow and prepare themselves for the future. Throughout the conversation, they discuss why leaders need to look past the optimism of short term relief, and why hospital-based health systems need to start working smarter and not harder. Links: [Tool] Market Scenario Planner Ep. 147: Pursuing growth in today's financial landscape [Rerun] The dire state of hospital finances (Part 1: Hospital of the Future series) Survey insights: 6 priorities for health system strategists in 2024 Ep. 161: Unwavering purpose, the creation of Ballad Health 3 reasons to prioritize comprehensive sleep services Need a quick answer to a healthcare question? Ask Advisory! Whether it's about where the market is headed, or how to navigate our website our team of experts are just a call or email away. Visit ask.advisory.com or email [email protected] to learn more. A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

Last week, in the first part of our series on what CEOs need to pay attention to in 2024, we discussed several of the seismic changes that have emerged in the healthcare industry. In particular, we discussed where care is delivered, and how the healthcare industry is shifting from hospital-first care delivery to vertically integrated ecosystems. In part two of our series, host Rachel (Rae) Woods welcomes back Advisory Board experts Natalie Trebes, Prianca Pai, and Sharon Yuen to discuss two other seismic shifts: who delivers care and how it’s paid for. In the conversation, they discuss how care team roles are shifting in a world of generative AI, how treatment economics are evolving in the new era of bespoke care, and more. Links: Ep. 191: What CEOs need to know in 2024 (Part 1) Bold predictions for healthcare in 2024 Ep. 189: A preview of Advisory Board's 2024 research 11 Things CEOs Need to Know in 2024 Improving detection of ATTR-CM: Insights from experts Learn about Advisory Board Sponsorship at advisory.com/sponsorship A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

As we step into 2024, there is no denying that the healthcare industry is vastly different than it was 5 years ago, 1 year ago, maybe even one month ago. As the immediacy of the pandemic has ebbed, several other seismic changes have emerged that promise to transform the core of the healthcare industry. Understandably, healthcare leaders are concerned about the pressures they face today and those that lie ahead in 2024. That's why, in part 1 of a two-part series on what CEOs need to know in 2024, host Rachel (Rae) Woods invites Advisory Board experts Natalie Trebes, Prianca Pai, and Sharon Yuen to unpack these seismic changes and discuss how leaders should be preparing for the future. Links: Bold predictions for healthcare in 2024 11 Things CEOs Need to Know in 2024 Ep. 189: A preview of Advisory Board's 2024 research Ep. 145: Part 1: What CEOs need to know in 2023 Learn about Advisory Board Sponsorship at advisory.com/sponsorship Advisory Board On-Demand Courses A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

Every year, Advisory Board receives thousands of questions from healthcare leaders about what's happening in the industry and how their organizations should respond. The team who answers these questions is called AskAdvisory – and today we're giving listeners a behind-the-scenes look at how these experts help leaders answer their most pressing questions. In Part 1 of this episode, host Rachel (Rae) Woods invites some of our AskAdvisory colleagues to answer some of the questions they've received this year. Then, in Part 2, Rae invites Chris Phelps, lead producer of the Radio Advisory team, to give listeners an inside look on how we make Radio Advisory. Links: The board’s guide to 5 AI challenges The Hospital Benchmark Generator Low-acuity fast track Market Scenario Planner National site-of-care shift maps Ep. 159: Ozempic, Wegovy, and our questions on weight management drugs Ep. 172: Build a value-based enterprise: Live from 2023 Value-Based Care Summit Ep. 145: Part 1: What CEOs need to know in 2023 Ep. 146: Part 2: What CEOs need to know in 2023 Encore: Revisiting our conversation on building ethical AI systems Ep. 173: 4 ways to prevent a physician shortage [Bonus content] Follow Advisory Board on Instagram A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

With the new year just around the corner, we wanted to take some time to reflect on everything we've researched in the last twelve months and set our research agenda for the year ahead. In 2023, we spent a lot of time focusing on how to overcome a difficult financial landscape, what AI means for the future of healthcare, and how the industry should reckon with new high-cost drugs. But what will we be focusing on in 2024? In this episode, guest host Rachel (Rae) Woods invites eleven (yes, you read that right) Advisory Board experts to discuss what exactly is on our radar in the new year and what you can expect to hear from us here at Radio Advisory throughout 2024. Topics include: (1:23) Strengthening care teams (4:20) Generative AI (6:44) Payer-provider partnerships (10:02) Future of hospital sustainability (11:57) Future of cancer care (14:51) Financing and integrating innovation (17:37) Ambulatory surgery center strategy (20:19) Value-based care performance Links: Ep. 144: What's on our radar for 2023 The best AI strategy isn't about AI How technology can help solve the workforce crisis 6 insights on the medical group landscape for 2024 [Webinar, Jan. 11, 2024] The future of cancer care — and how to prepare 4 essential EOY conversations to have with your nursing team 3 takeaways from our latest webinar on AI in healthcare A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

Women experience healthcare differently compared to men – women consistently have worse outcomes when it comes to chronic diseases, feel unheard, and are oftentimes left out of education and research. Women's health also gets conflated with maternal health, but we know women's health is so much bigger than pregnancy. Improving women's health outcomes requires a more holistic approach to caring for women, but allocating more dollars when working with limited resources may feel unsustainable to some organizations. In this episode, host Rachel (Rae) Woods invites Advisory Board's Gaby Marmolejos, Kara Marlatt, and Ellie Wiles to discuss why there's a strong business case to better meet women's needs, including but not limited to maternal health. Links: 6 things to understand about women's health in the United States 5 steps to improve women's health and well-being How to Grow Share of Wallet with Women's Primary Care Ep. 175: We need to talk about maternal health in America [Bonus content] [Infographic] How healthy is your structural heart program? A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

It's no secret that the US is in the midst of a behavioral health crisis—and with the impacts of unmet need affecting every corner of the industry, many leaders are feeling powerless to sustainably address it. In this episode, guest host Abby Burns invites ChristianaCare's Chief Biopsychosocial Officer, Erin Booker, to discuss how Erin is driving—and making the case for—a comprehensive and holistic behavioral healthcare strategy. Erin shares how she converted her CFO to be a champion for integrated behavioral healthcare, as well as how she approaches workforce challenges, partnership, and policy advancement. Links: ChristianaCare's website Ep. 154: The behavioral health crisis won't change (unless we do) The 5 root causes of behavioral health inequity Ep. 68: Seattle Children's approach to behavioral health Tactics to build a stronger behavioral health system Learn more about Advisory Board's on-demand courses A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

In the past few months, we have talked a lot about high-cost drugs. We've done episodes on new innovations, equity implications, the rise of weight management drugs and more. While there is a lot to be excited about, there is a lot to be anxious about too, like high costs and impending legislation. A lot of the industry is tempted to "wait and see" what the new era of drugs will bring, but the reality is that "new era" is already here. That's why, in this episode, host Rachel (Rae) Woods invites Advisory Board pharmacy experts Rachael Peroutky and Chloe Bakst to discuss how the industry should be thinking about this new era of drugs, and why healthcare organizations can't afford to sit around today and strategize later. Links: Ep. 177: Advancing equity in a world of innovation for some, costs for all: Live from the 2023 Clinical Innovation Summit Ep. 167: How nervous should we be about high-cost drugs? Ep. 159: Ozempic, Wegovy, and our questions on weight management drugs [Webinar Recording] State of the Industry: How high-cost drugs change everything Read Advisory Board's case study about how University of Michigan Health-West improved clinician well-being with Nuance's Dragon Ambient eXperience (DAX). A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

It is no question that we are in an unprecedented era of technological change. Large language models and the rise of generative AI have dominated industry conversations in recent months, and for good reasons. It's clear that AI is here to stay, but what isn't so clear is how the industry should adopt it. Should you run headfirst into experimentation? Or wait for data and case studies before implementation? In this episode, host Rachel (Rae) Woods invites Advisory Board digital health experts Ty Aderhold and Elysia Culver to discuss how the industry needs to be thinking about AI adoption and integration. Throughout the conversation, they discuss what we can (and cannot) learn from past technologies, what it means to be an "early mover" or "fast follower," and why taking an incremental approach can empower your business strategy. Have a healthcare question? Want to learn more about what goes on behind-the-scenes at Radio Advisory? Submit your question and we may use it in our final episode of 2024! Email [email protected] or leave us a voice message by Thanksgiving for consideration. Thanks! Links: The best AI strategy isn't about AI Overcoming AI challenges to unlock potential Leading the way: How health system executives approach AI in healthcare Ep. 180: Tom Lawry on why AI has a PR problem Ep. 138: Microsoft's head of AI on building ethical systems Visit advisory.com/AIstrategy to learn what's necessary for AI to drive transformative outcomes in the healthcare landscape. A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

During the COVID-19 Public Health Emergency, the federal government and insurers implemented several measures to expand coverage options and better ensure ease of access to healthcare services. One of the most significant policies was the expansion of Medicaid programs and the requirement that individuals be continuously enrolled through the end of the PHE. The expanded eligibility ended when the PHE expired in May 2023, and the industry is reeling from the whiplash of coverage changes. In this episode, host Rachel (Rae) Woods invites Advisory Board health plan experts Chelsea Needham and Sally Kim to discuss what you need to know about Medicaid redeterminations, how health plans are responding, and what this means for the healthcare industry. Have a healthcare question? Want to learn more about what goes on behind-the-scenes at Radio Advisory? Submit your question and we may use it in our final episode of 2024! Email [email protected] or leave us a voice message by Thanksgiving for consideration. Thanks! Links: A deep dive into the end of the COVID PHE A 'staggering' 15M+ Americans could lose Medicaid coverage Why are 600+ rural hospitals at risk of closing? C-Suite Cheat Sheet: Medicaid Expansion Visit advisory.com/expertsupport to learn how you can bring Advisory Board experts to your organization to deliver presentations, workshops, and more on AI and other topics that keep healthcare leaders up at night. A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

As healthcare organizations look for ways to weather financial hardships, many leaders are looking at strategic partnerships to sustain their business. The word "partnership" gets thrown around a lot in healthcare and can mean a lot of different things. But what defines a good partnership, and how do you know if one is right for your organization? In this episode, Host Rachel (Rae) Woods invites John Muir Chief Strategy Officer George Sauter and President of Optum's Market Performance Partnership Chris Pass to discuss why they decided to partner back in 2019, what they've gained, where they had to compromise, and how they define success. Have a healthcare question? Want to learn more about what goes on behind-the-scenes at Radio Advisory? Submit your question and we may use it in our final episode of 2024! Email [email protected] or leave us a voice message by Thanksgiving for consideration. Thanks! Links: Deep dive: 5 partnership models in commercial risk 4 signs your VBC arrangement isn't a true partnership [Webinar] Playbook for Partnership (Part 2): Five Principles For Effective Relationships Our Leadership playlist Our Strategy playlist Join Advisory Board for a webinar on November 13 at 1pm EST to learn about recent trends and growing capabilities in remote patient monitoring. Click here to learn more. A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

In recent years the delivery system has been strapped, to say the least. Any opportunity for financial stabilization and revenue diversification are sitting top of mind for provider executives. One place organizations are searching for lifelines is overseas, as more and more health systems are partnering internationally. No, it’s not just med tech and life sciences going global – health systems are looking overseas to advance their business objectives as well. In this episode, host Rachel (Rae) Woods invites Advisory Board international experts Paul Trigonoplos and Isis Monteiro to discuss why interest in global partnerships are accelerating, how organizations are leveraging these partnerships, and whether it’s a good idea for all health systems to go global. Ask us a question and hear it on the pod! Email us at [email protected], visit ask.advisory.com, or leave a voicemail at radioadvisory.advisory.com. Links: Ep. 152: The global workforce crisis (and possible solutions) We polled 50+ health system executives on their global partnership strategy. 3 things surprised us. 5 goals health systems are pursuing through international ventures Your guide to global health system partnerships The 5 things we're watching in international healthcare in 2023 Join Advisory Board experts on Thursday, November 2 at 1 p.m. ET for a webinar where you’ll learn everything you need to know about the different types of AI, how these technologies are being used by healthcare organizations, common implementation pitfalls – and how to avoid them. Visit advisory.com/AIstrategy and register now. A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

In recent decades, billions of dollars have gone towards programs aimed at curbing obesity in the U.S., yet the prevalence of obesity remains high. Weight management drugs like Ozempic and Wegovy have come to public awareness recently, though these drugs are often expensive and hard to access, leaving patients to receive the industry's traditional approach to weight management. But are these approaches even helpful? In this episode, host Rachel Woods invites health equity expert Darby Sullivan and pharmacy expert Chloe Bakst to discuss how the healthcare industry thinks about weight management, why the current approaches may be doing more harm than good, and how healthcare leaders need to think differently about treating obesity and weight. Ask us a question and hear it on the pod! Email us at [email protected], visit ask.advisory.com, or leave a voicemail at radioadvisory.advisory.com. Links: Ep. 159: Ozempic, Wegovy, and our questions on weight management drugs 3 missteps in our approach to treating obesity (and 5 ways to fix it) The 5 biggest weight management drug questions (and our answers) What the headlines get wrong about weight-management medications Learn about Advisory Board Sponsorship at advisory.com/sponsorship A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

In last week's episode, we discussed why technology is a non-negotiable tool for alleviating the workforce crisis. While we talked about many technologies, we didn't talk much about one of the most transformational forces in the healthcare industry today: Artificial Intelligence. There is so much buzz, and so much fear about the topic, that we wanted to dedicate an episode to it. In this episode host Rachel (Rae) Woods invites back fan-favorite guest Tom Lawry, a top thought leader on artificial intelligence, bestselling author, and the former head of AI for Microsoft. Last year, Tom was part of an award-winning Radio Advisory episode on bias and AI. In this episode, Rae and Tom will discuss frustrations, fears, and the wealth of opportunities that generative AI brings the healthcare industry. They also discuss myths around AI, and why leaders should stop worrying about existential threats and start imagining the existential opportunity this technology provides. Links: Ep. 138: Microsoft's head of AI on building ethical systems Ep. 179: Future-proofing healthcare requires a tech-enabled workforce How will AI change healthcare? Look at the internet for parallels. Generative artificial intelligence TomLawry.com Visit advisory.com/AI101 to learn more about Advisory Board's upcoming AI and Generative AI 101 webinar. Learn more about how you can make the best use of AI and prepare your organization for the future with Advisory Board's Expert Support. A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

It's no secret that the industry is in the midst of a serious workforce crisis. For years, leaders have employed strategies primarily looking to mitigate the crisis with short-term solutions without addressing the root-causes of clinician burnout and workforce shortages. However, today we want to talk about a non-negotiable tactic that can work to address these root problems: technology. In this episode, host Rachel (Rae) Woods invites Advisory Board experts Allyson Paiewonsky and Jordan Peterson to discuss what organizations are getting wrong about tech and how it can work to sustainably alleviate the workforce crisis in the long term. Throughout the conversation, they discuss emerging technologies, why the industry needs to think differently about workforce solutions, and how leaders can work with the resources that they already have. Links: Ep. 173: 4 ways to prevent a physician shortage [Bonus content] Ep. 162: Addressing the workforce crisis: Insights from University Hospitals' leaders 12 technologies to address your clinical workforce challenges How technology can help solve the workforce crisis Learn more about the Advisory Board Fellowship at: advisory.com/fellowship A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

Value-based care has been dominating industry conversations in recent years. Here on Radio Advisory, we talk a lot about best practices, how to make the right investments, and how to best prepare leaders for the future of value-based care. But given all this momentum, we want to spend time asking the question: what are the misconceptions or misaligned expectations that leaders have around value-based care? In this episode, host Rachel (Rae) Woods invites Advisory Board value-based care expert Daniel Kuzmanovich and Optum Advisory Service's SVP of value-based care, Erik Johnson, to discuss the mindset shifts they think leaders should be making when pursuing a sustainable value-based care strategy. Throughout the conversation they discuss what leaders are currently getting wrong, how myths about value-based care are impacting the industry, and more. Links: Ep. 172: Build a value-based enterprise: Live from 2023 Value-Based Care Summit Ep. 126: [Bonus content] Commercial risk is possible—here's how How Health Plans Can Support Providers in Risk The climb to value-based care [Upcoming Roundtable, Nov. 9-10] Shaping the New Era of Value-Based Care Learn more about Advisory Board's value-based care on-demand courses Explore what volumes and revenues a structural heart program could capture in different scenarios, with Advisory Board's new calculator, sponsored by Edwards Lifesciences. Advisory Board is a subsidiary of Optum. All Advisory Board research, expert perspectives, and recommendations remain independent.

With so many clinical innovations abound, it's easy to get excited about groundbreaking drugs, consumer technologies and even possible cures for rare diseases. However, the industry must recognize its own limitations in order to make these advancements accessible and equitable. At the end of August, hundreds of healthcare leaders gathered at Advisory Board's Clinical Innovation Summit in Minneapolis to learn about the implications of the transformation of patient care across the industry. The Radio Advisory team orchestrated a live podcast recording with thought leaders across the industry to talk about embedding equity in innovation. In this special live episode of Radio Advisory, host Rachel (Rae) Woods invites Maia Laing, SVP of Health Equity for UnitedHealth Group, and Michael Mejia, Advisory Board's director of life sciences research, to discuss how leaders can think about deploying, designing, and financing clinical innovations in an equitable way. Throughout the conversation, they discuss how payers and providers – not just life sciences – can rethink their practices to ensure advancements in innovation are shared equitably. Links: Dive into topics like AI and weight management drugs at Advisory Board’s Virtual Clinical Innovation Summit, coming up on October 4-5. Learn more and register. 7 trends shaping life sciences strategies in 2023 Health Equity landing page Learn more about Advisory Board Summits Need a quick answer to a healthcare question? Ask Advisory! Whether it's about where the market is headed, or how to navigate our website our team of experts are just a call or email away. Visit ask.advisory.com or email [email protected] to learn more. Advisory Board is a subsidiary of UnitedHealth Group. All Advisory Board research, expert perspectives, and recommendations remain independent.

With rising costs and tightening margins, the industry is continually looking for ways to "bend the cost curve" while maintaining, or even increasing, quality and performance. One stakeholder in particular, employers, are feeling significant pressures from inflation, hospital consolidation, the rise of high-cost drugs, and more. While many legacy cost-saving strategies have focused on reducing employer costs, it may be time to shift focus to lowering costs for employees as well. In this episode, host Rachel (Rae) Woods invites Advisory Board payer expert Max Hakanson and Innovation lead at JPMorgan's Morgan Health Rivka Friedman to discuss what employers can do to rein in healthcare costs, both for themselves and their employees. Throughout the discussion, they discuss why legacy cost-sharing strategies may be insufficient, and what new innovations are showing promise in the market. Join Rae for a free webinar on Advisory Board's State of the Healthcare Industry. In this webinar, you'll get Advisory Board’s exclusive take on the strategic forces that really matter. Rae will talk about the rise of artificial intelligence and why you should not be asking "what should my AI strategy be?". Save your seat and join Rae on September 18th at 2:00 PM ET. Links: Home | Morgan Health Ep. 165: Employer series: Is the cost of employer-sponsored insurance unsustainable? Investigating the high costs in employer-sponsored insurance 5 health benefits strategies for self-funded employers 3 things to know about ESI (that you won't find in a benefits survey) Need a quick answer to a healthcare question? Ask Advisory! Whether it's about where the market is headed, or how to navigate our website our team of experts are just a call or email away. Visit ask.advisory.com or email [email protected] to learn more.

This week’s episode comes from one of our favorite healthcare podcasts, See You Now, which shines a light on the real people changing the status quo in health, created in collaboration with Johnson & Johnson and the American Nurses Association. Racism in America remains pervasive. It’s led to sicker, shorter lives for people of color; a healthcare workforce that hasn’t reflected the communities it cares for; and caused harm to nursing and nurses, particularly nurses of color. Aware of its own role in perpetuating systemic racism, the American Nurses Association (ANA) is on a journey of racial reckoning along with many partners inside and outside of nursing and healthcare. In this two-part episode, we hear from leaders in nursing, media, and life sciences industry about how they are leaning into racial reckoning in their organizations to address and eliminate the harms of racism. In Part I, Shawna Butler, RN MBA and co-host Lucinda Canty, PhD, CNM, FACNM engage in thoughtful and forthright dialog with Cheryl Peterson, MSN, RN about the ANA's Racial Reckoning Statement; how it led to the creation of the National Commission to Address Racism in Nursing; and the work the ANA has committed to in moving forward to antiracist practices, policies, and nursing profession. Links: [See You Now] Episode 91: Reckoning with Racism (Part I) Shawna Butler, RN MBA Lucinda Canty, PhD, CNM, FACNM Cheryl Peterson, MSN, RN Visit the See You Now podcast site: www.seeyounowpodcast.com Free CNE's from the ANA for listening to See You Now episodes Episode-specific resources: ANA: Our Racial Reckoning Statement National Commission to Address Racism in Nursing Racial Discrimination in Healthcare: How Structural Racism Affects Healthcare Structural Racism In Historical And Modern US Health Care Policy The Sum of Us: What Racism Cost Everyone and How We Can Prosper Together What Racism Costs Us All New survey shows racism is a huge problem in nursing Key Takeaways from ANA's Racial Reckoning Statement Advisory Board resources on health equity and racism: Our health equity and racism Playlist 4 ways to develop a 'speak up' culture at your organization Health Equity landing page The time is now to invest in your BIPOC leaders. Build an inclusive leadership team with Advisory Board Fellowship. Learn more about Advisory Board on-demand courses

This week, we are revisiting episode 2 of our "Senior Care Series" from February 2023. This episode is still very relevant, but we do have some important updates that we’ve included at the beginning. Medicare Advantage is a public-private hybrid health plan that allows eligible seniors to receive health insurance through a commercial insurer. It has a high satisfaction rate among enrollees and has crested more than fifty percent of all Medicare enrollment this year. In part two of Radio Advisory's senior care series, host Rachel (Rae) Woods provides an update on new policies and regulatory scrutiny that are impacting the program. We also will revisit her conversation with senior care expert Aaron Hill and health plan expert Max Hakanson about why Medicare Advantage is so popular and its impact on industry stakeholders. Links: Ep. 150: Senior Care (Part 2): The rapid growth of Medicare Advantage Ep. 149: Senior Care (Part 1): Specialized primary care for an aging population Achieving sustainable growth in Medicare Advantage 9 data-driven insights on senior preferences when selecting a Medicare Advantage plan Shifting the balance of VBC in Medicare Advantage 2024 Risk Adjustment Data Validation final rule Learn more about Advisory Board On-Demand Courses Take our RN workforce survey at: advisory.com/RNsurvey

This week, we are revisiting episode 1 of our "Hospital of the Future series” which was initially released all the way back in November 2022. The majority of hospitals are predicted to have negative margins in 2022, marking the worst year financially for hospitals since the beginning of the Covid-19 pandemic. In Part 1 of Radio Advisory’s Hospital of the Future series, host Rachel (Rae) Woods invites healthcare business experts Monica Westhead, Aaron Mauck, and Colin Gelbaugh to discuss why factors like workforce shortages, post-acute financial instability, and growing competition are contributing to this troubling financial landscape and how hospitals are tackling these problems. Links: 'The most difficult year': Why hospital finances are so strained Our Financial Impact playlist Services at risk of shifting from the hospital setting What you need to know about out-of-market travel for surgery 10 takeaways from our cost management intensive Take our RN workforce survey at: advisory.com/RNsurvey Learn more about Advisory Board On-Demand Courses

(New/bonus content starts at 24:11. First part of episode originally aired October 5, 2021.) This week, Radio Advisory is bringing you an encore of Ep. 91: We need to talk about maternal health in America, where host Rachel (Rae) Woods invites Advisory Board Expert Darby Sullivan and Optum Director of social responsibility Callie Chamberlain to discuss the dire state of maternal health in America. Following the original episode, in a special bonus segment, host Rae Woods brings back Advisory Board health equity expert Darby Sullivan and invites women’s health expert Gaby Marmolejos to discuss why maternal health, and women’s health more broadly, are only getting worse. In the conversation, they discuss what is driving poor maternal outcomes and why there needs to be a massive shift in how the industry thinks about maternal health moving forward. This episode was recorded before the FDA approved Zurzuvae (zuranolone), the first ever pill to treat post-partum depression. Postpartum depression is a condition that affects one in eight new mothers. Previously, the only treatment available was an IV infusion approved by the FDA, which required patients to be in the hospital for 2.5 days. The move underscores the industries' need to focus on behavioral health in the postpartum period and on women’s health more broadly. Links: Ep. 91: We need to talk about maternal health in America Revisiting our Dobbs v. Jackson predictions, 1 year later What's driving the 'shocking disparities' in maternal health outcomes? Around the nation: FDA approves first pill for postpartum depression Addressing the Root Causes of Maternal Health Inequity [JAMA] Trends in Maternal Mortality and Severe Maternal Morbidity During Delivery-Related Hospitalizations in the United States, 2008 to 2021 Learn more about Advisory Board On-Demand Courses Visit advisory.com/workforce to get research and insights that will help you understand the current challenges providers are facing and learn how technology – including platforms you may already have – can address healthcare's biggest staffing and care delivery challenges. Advisory Board is a subsidiary of Optum. All Advisory Board research, expert perspectives, and recommendations remain independent.

In recent years, there has been a major influx of new genetic tests that have hit the market. While these tests promise to revolutionize diagnostics and treatment decision-making, the industry needs to overcome a variety of reimbursement and logistical barriers to achieve any goals for genomics at scale. In this episode, guest host and Advisory Board expert partner Devin Airey invites Mark Gardner, the SVP of Genomic Medicine and Oncology at Quest Diagnostics, and Dan Edelstein, President and CEO of Haystack Oncology, to discuss their vision for genomics at scale. Throughout the conversation, they discuss increased attention from providers and purchasers, how to integrate new genomics technology into patient care, and how to address opportunities and concerns in the market. Links: 6 questions shaping the future of oncology screening and diagnostics What liquid biopsies could mean for cancer treatment and disease monitoring Home | Quest Diagnostics Haystack Oncology – Better decisions with better MRD testing Quest Diagnostics to Acquire Haystack Oncology, Adding Sensitive Liquid Biopsy Technology for Improving Personalized Cancer Care to Oncology Portfolio [Webinar] Consumer insights decision makers should lead with in 2023 (August 24 | 3-4pm ET)

(New/bonus content starts at 19:50.) This week, Radio Advisory is bringing you an encore edition of 4 ways to prevent a physician shortage, which originally aired in May 2022. Host Rachel (Rae) Woods invites Advisory Board experts Daniel Kuzmanovich and Sebastian Beckmann to discuss the threats and realities of a physician shortage. Following the original podcast, in a special bonus segment, host Rae Woods passes the mic to Eliza Dailey and Sydney Moondra to discuss how Advanced practice providers (APPs) are, and will continue to, radically transform the physician landscape. Links: How to prevent a primary care shortage Deploying APPs Autonomously Physician employment is changing. What does that mean for the industry? Is there really a primary care shortage? Four keys to maximizing advanced practice provider (APP) ROI Ep. 96 Why the headlines are wrong about physician shortages Learn more and register for the 2023 Advisory Board Clinical Innovation Summit [August 22-23, 2023]

While value-based care has been at the forefront of industry conversations in the last decade, there are still a lot of questions about how to successfully create and thrive as a value-based enterprise. At the end of June, around 300 healthcare leaders gathered at Advisory Board’s Value-Based Care Summit with one shared goal: make the next 10 years of VBC more impactful from the last. As part of the event, the Radio Advisory team orchestrated a live podcast recording with three renowned leaders at the helm of very different organizations – all trying to build value-based enterprises. In this special live episode of Radio Advisory, host Rachel (Rae) Woods invites Rob Mayer, senior vice president and GM of Optum Insight Clinical Solutions; Laurie Sicaeros, Chief Strategy Officer at Memorial Care Health System; and Rushika Fernandopulle, Co-Founder and Former CEO of Iora Health, to discuss building a value-based enterprise, what defines success, and what capabilities and assets are needed to succeed. Links: The climb to value-based care Introduction to the series: Envisioning paths to nationwide VBC Ep. 166: Employer series: The role of employers in value-based care Ep. 113: What it will take to get to meaningful risk Advisory Board is a subsidiary of Optum. All Advisory Board research, expert perspectives, and recommendations remain independent.

In the last two weeks, we discussed the use of consumer data and how the FTC is using its power to respond to data privacy concerns. While there are stakeholders who are taking action in response, we wanted to explore a key question: what happens when the concerns raised are left unchecked? Following the 2022 Dobbs v. Jackson decision that overturned Roe v. Wade, we seem to have a test case. In part three of Radio Advisory’s series on consumer data, host Rachel Woods invites Advisory Board experts Ty Aderhold and John League to discuss how the Dobbs decision impacts conversations around data privacy and how healthcare leaders should be thinking about protecting patient reproductive data. Links: Ep. 170: Data privacy and the FTC: Who is working to protect your data? Ep. 169: Innovative or invasive? How consumer data is changing healthcare Revisiting our Dobbs v. Jackson predictions, 1 year later Ep. 121: Researchers react: Roe is overturned Roe v. Wade is overturned. Are you ready to answer these questions? Dobbs v. Jackson: Key impacts across health care Learn more about Advisory Board On-Demand Courses

In the last episode, we discussed how different industry stakeholders are taking advantage and navigating the challenges of the use of consumer data in healthcare. While the industry wrestles with some concerns about data privacy, the question remains: who is working to protect the data of consumers and patients? In part two of Advisory Board’s series on consumer data, host Rachel Woods invites Advisory Board experts Ty Aderhold, Sara Zargham, and Paul Trigonoplos to discuss one stakeholder that is making moves to protect data privacy: the FTC. In the conversation, they explore recent regulatory actions taken by the FTC and what this means for the industry. Links: Ep. 169: Innovative or invasive? How consumer data is changing healthcare Around the nation: FTC issues warning about usage of consumers' biometric data Winners and losers from FTC's increased focus on consumer privacy in healthcare Anonymity in the digital age [HealthAffairs.org] Widespread Third-Party Tracking On Hospital Websites Poses Privacy Risks For Patients And Legal Liability For Hospitals [FTC.gov] FTC Warns Health Apps and Connected Device Companies to Comply With Health Breach Notification Rule [nytimes.com] How Companies Learn Your Secrets Check out this recent Advisory Board blog post about how to address 5 common challenges seniors face in cancer care

For years, consumers have felt the effects of the increased use of their data. From receiving targeted advertisements to personalized recommendations online, it is no secret that giants in various industries are taking advantage of complex consumer data. But how does this look in the healthcare space? In part one of a new three-part series on consumer data, host Rachel Woods invites Advisory Board experts Solomon Banjo and Ty Aderhold to discuss how various industry players are taking advantage and navigating the challenges of the use of consumer data in healthcare. In the conversation, they explore exactly what kind of information is being used, what this means for various stakeholders, and how the rising use of consumer health data is poised to radically change the industry. Links: HHS: How to handle reproductive health data after Dobbs v. Jackson 'Deeply troubled': Security experts worry about Facebook trackers on hospital sites Around the nation: FTC issues warning about usage of consumers' biometric data Winners and losers from FTC's increased focus on consumer privacy in healthcare How Companies Learn Your Secrets Learn more about Advisory Board’s upcoming webinar on key innovations in cancer care for patients by visiting https://www.advisory.com/resources/events

For years Advisory Board has been researching how technology and macro-economic forces are shaping clinical decision-making, and recent advances in large language models and AI have the potential to make an impact like we’ve never seen before. In this episode, guest host and Advisory Board life sciences expert Soloman Banjo invites Advisory Board expert Amanda Okaka and Optum’s Senior Vice President of Clinical Innovation Dr. Kevin Larson to discuss the technologies that will change clinical decision-making in the next decade, its implications, and what organizations should be thinking about as they integrate them into clinical workflows. Links: How clinicians will use evidence in 2032 5 takeaways from our expert panel on technology's role in the future of clinical decision-making The future of clinical decision-making at the institutional level Learn more about Advisory Board’s upcoming webinar on key innovations in cancer care for patients by visiting https://www.advisory.com/resources/events Advisory Board is a subsidiary of Optum. All Advisory Board research, expert perspectives, and recommendations remain independent.

With a variety of new (and expensive) therapies in the pipeline for 2023, it is understandable that the industry is feeling anxiety over the rise of high-cost drugs. However, there is not one-size-fits all solution. Industry stakeholders must consider and respond differently to each drug type. In this episode, host Rachel (Rae) Woods invites Advisory Board pharmacy experts Gina Lohr and Chloe Bakst to discuss how industry stakeholders are thinking about different high-cost drugs and how they can prepare for the future. Links: Ep. 134: Can Mark Cuban solve our drug cost problems? Ep. 159: Ozempic, Wegovy, and our questions on weight management drugs Why 'cash' pharmacies are booming—and what it means for healthcare These 4 groups will benefit most from drug pricing reform Ultra high-cost drugs Contracts to Mitigate Risks from Ultra High-Cost Drugs Learn more about Advisory Board On-Demand Courses

Last week we discussed the current state of employer-sponsored insurance and the affordability challenges that the employers are facing. This week, we'll be taking a look at one possible solution for employers: value-based care. In this episode, host Rachel (Rae) Woods invites Advisory Board value-based care experts Daniel Kuzmanovich and Sophia Hurr to discuss the opportunity that value-based care presents for employers to reduce the costs of care while increasing the quality of care their employees receive. Throughout the conversation, they explore what kinds of employers are best positioned to pursue value-based care, and the different paths to get there. Links: Ep. 165: Employer series: Is the cost of employer-sponsored insurance unsustainable? 3 employer archetypes in value-based care Introduction to the series: Envisioning paths to nationwide VBC Our Value-Based Care playlist [June 26-27, 2023] Advisory Board Summit: Shaping the New Era of Value-Based Care Learn more about Advisory Board Events at advisory.com/resources/events

While always facing a dynamic landscape, one of the biggest issues today in the employer-sponsored insurance market is affordability. As healthcare costs continue to rise, employers are getting increasingly nervous about their ability to pay for employees’ health insurance, especially in a time of heightened worker shortages. In this episode, guest host and Advisory Board Vice President and spokesperson Aaron Mauck discusses employer market affordability with Advisory Board health plan experts Sally Kim and Max Hakanson. Throughout the conversation, they explore the context of the problem, root causes, and what the future may look like for employer-sponsored insurance. Links: 4 big ways employers are changing health benefits in 2023 The cost of employer-sponsored insurance is about to spike—again Mark Cuban is taking on the self-insured employer drug market Ready-to-use market outlook slides for health plans Learn more about Advisory Board On-Demand Courses

Episode 138 was originally released on October 25, 2022. This week, we're bringing you an encore of our episode with Tom Lawry, the former national director for AI at Microsoft about building ethical AI systems. Not only did this episode recently receive accolades from this year's Communicator Awards – including best healthcare and pharma episode and best business episode – but this conversation is just as, if not more relevant as it was when we recorded it in the Fall of 2022. While we have a lot to learn about these new technologies, it is clear that AI is top of mind for digital health leaders in 2023. However, revelations about equity issues and bias in artificial intelligence are increasingly giving cause for concern. In this encore of Episode 138, Rachel (Rae) Woods invites Microsoft's former Director for Artificial Intelligence Tom Lawry to discuss how bias creeps into AI and how leaders can respond to make intelligent systems more equitable. Tom Lawry is the author of Hacking Healthcare, which details lessons learned from AI's role during global pandemic and how to apply this knowledge to healthcare’s other big challenges – including inequity. Links: [Tom's book] Hacking Healthcare: How AI and the Intelligence Revolution Will Reboot an Ailing System AI in healthcare What does the future of AI in cancer care look like? Here are 3 global start-ups that we're watching to decide. Prep for a new era of AI and analytics: 5 insights from Advisory Board's 2022 AI and analytics survey Ep. 103: What an equitable organization looks like and how yours can get there Our Technology playlist Our Health Equity and Racism playlist Learn more about Advisory Board Events at advisory.com/resources/events

Hospitals and health systems across the globe are looking towards environmental sustainability. However, in a tumultuous economic environment, it can be challenging to balance sustainability efforts with bottom-line necessities while operating under tight margins. In this episode, guest host and Advisory Board's environmental sustainability expert Miles Cottier invites Bob Biggio, Senior Vice President of Facilities & Support Services at Boston Medical Center, to discuss long-term green financing strategies. Throughout the discussion, they explore Boston Medical Center's medical campus redesign, issuing of "Green Bonds," and their efforts balance sustainability with efficiency and cost-savings. Links: The 5 things we're watching in international healthcare in 2023 How can you make progress on environmental sustainability? By defining the problem and asking the right questions. Ep. 119: How health leaders can address climate change Here's how hospitals can chart a path to a sustainable financial future Three ways your climate change inaction will hurt your bottom line What health system strategists will prioritize in 2023 and beyond Learn more about Advisory Board Events at advisory.com/resources/events